Severe Hypocalcemia Causing Bradycardia Following Red Blood Cell Transfusion

Introduction: Cardiovascular manifestations of acute hypocalcemia include hypotension and reversible myocardial dysfunction. There is limited literature on bradycardia as a feature of hypocalcemia. Citrate-phosphate-dextrose (CPD) is used as an anticoagulant-preservative of red cell units and has been associated with hypocalcemia. Case Description: A 48-year-old man with hypertension and end-stage renal disease due to focal segmental glomerulosclerosis who received a kidney transplant 21 years before was admitted to the hospital due to elevated creatinine. He had not seen a nephrologist in the last 2 years. He stated he felt well and was compliant with cyclosporine, prednisone and amlodipine. Serum creatinine was 9.7, increased from baseline 4.3 mg/dL. Physical exam was benign except for 2+ edema below the knees, heart rate (HR) was 60. Other laboratory analyses were significant for calcium 6.2 mg/dL with albumin 3 g/dL and hemoglobin 6.6 g/dL. In anticipation of transplant kidney biopsy, transfusion of 1 red cell unit was initiated. He became progressively bradycardic with nadir HR 38, though normotensive and asymptomatic. Point-of-care ionized calcium was 0.89 mEq/L. Calcium gluconate 2 g IV was given with improvement in HR. Amlodipine was discontinued. A second unit was transfused without issue; however, bradycardia recurred during a third RBC unit the next day. Discussion: We report a case with a clear and repeated temporal relation between blood transfusion, worsening hypocalcemia (due to citrate in CPD) and bradycardia. Dihydropyridine calcium channel blockers such as amlodipine may cause reflex tachycardia rather than bradycardia. This is not a case of BRASH syndrome as our patient was not on AV blocking agents nor had hypotension or hyperkalemia. Renal failure was due to graft loss from severe interstitial fibrosis noted on the aglomerular biopsy sample. Animal models suggest high extracellular potassium in old (40-50 days) red cells may induce bradycardia. All units given to our patient were before 30 days from donation. Thus, we conclude that bradycardia may be a manifestation of hypocalcemia.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025nr3n5f8n
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severe Hypocalcemia Causing Bradycardia Following Red Blood Cell Transfusion

Juan Salvatierra, Rohini Rao, Blaithin A. McMahon, Daniel Carpin
Journal of the American Society of Nephrology
Blood groups and transfusion
article

Severe Hypocalcemia Causing Bradycardia Following Red Blood Cell Transfusion

Juan Salvatierra, Rohini Rao, Blaithin A. McMahon, Daniel Carpin
article en

Abstract

Introduction: Cardiovascular manifestations of acute hypocalcemia include hypotension and reversible myocardial dysfunction. There is limited literature on bradycardia as a feature of hypocalcemia. Citrate-phosphate-dextrose (CPD) is used as an anticoagulant-preservative of red cell units and has been associated with hypocalcemia. Case Description: A 48-year-old man with hypertension and end-stage renal disease due to focal segmental glomerulosclerosis who received a kidney transplant 21 years before was admitted to the hospital due to elevated creatinine. He had not seen a nephrologist in the last 2 years. He stated he felt well and was compliant with cyclosporine, prednisone and amlodipine. Serum creatinine was 9.7, increased from baseline 4.3 mg/dL. Physical exam was benign except for 2+ edema below the knees, heart rate (HR) was 60. Other laboratory analyses were significant for calcium 6.2 mg/dL with albumin 3 g/dL and hemoglobin 6.6 g/dL. In anticipation of transplant kidney biopsy, transfusion of 1 red cell unit was initiated. He became progressively bradycardic with nadir HR 38, though normotensive and asymptomatic. Point-of-care ionized calcium was 0.89 mEq/L. Calcium gluconate 2 g IV was given with improvement in HR. Amlodipine was discontinued. A second unit was transfused without issue; however, bradycardia recurred during a third RBC unit the next day. Discussion: We report a case with a clear and repeated temporal relation between blood transfusion, worsening hypocalcemia (due to citrate in CPD) and bradycardia. Dihydropyridine calcium channel blockers such as amlodipine may cause reflex tachycardia rather than bradycardia. This is not a case of BRASH syndrome as our patient was not on AV blocking agents nor had hypotension or hyperkalemia. Renal failure was due to graft loss from severe interstitial fibrosis noted on the aglomerular biopsy sample. Animal models suggest high extracellular potassium in old (40-50 days) red cells may induce bradycardia. All units given to our patient were before 30 days from donation. Thus, we conclude that bradycardia may be a manifestation of hypocalcemia.

Journal of the American Society of NephrologyVol. 36(10S)
Medical University of South Carolina (US)
Openalex Percentile: Top 62%
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.